These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16008652)

  • 21. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 27. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
    Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
    Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind controlled clinical trial to assess the role of anti-histamines in the treatment of multi-bacillary leprosy.
    Thomas A; Nagarajan M; Chandrasekaran V; Hari L; Somasundaram PR; Prabhakar R; Kumar A; Bhatia VN; Roy RG
    Indian J Lepr; 1988 Oct; 60(4):499-505. PubMed ID: 3075630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does clofazimine have a prophylactic role against neuritis?
    Arunthathi S; Satheesh KK
    Lepr Rev; 1997 Sep; 68(3):233-41. PubMed ID: 9364824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leprosy: identification of an isolated case].
    Fernández Galán MA; Borbujo Martínez J; Fernández Capitán MC; Casado Jiménez M
    Rev Clin Esp; 1992 Jan; 190(1):24-6. PubMed ID: 1546198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Leprosy - An overview from a pediatric perspective].
    Magdorf K; Haas WH; Harms D; Höger PH; Griese M; Rank M
    Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing picture of leprosy in North Arcot District, Tamil Nadu after M.D.T.
    Ekambaram V; Rao MK
    Indian J Lepr; 1989 Jan; 61(1):31-43. PubMed ID: 2784822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 40. Histoid leprosy; report of three cases.
    Krishna KK
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):174-6. PubMed ID: 10472376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.